- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 77.11M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $8.74M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.28M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $35.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.11M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $36.34M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $45.49M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $54.41M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $59.44M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $68.91M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 49.04M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$5.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $33.36M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $38.68M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.18M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.08M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$5.7M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$6.25M |